Memantine and ACPC affect conditioned place preference induced by cocaine in rats

Polish Journal of Pharmacology

Volumn 52, Issue 3, 2000, Pages 179-185

  Kotlińska, Jolanta ^a   Biała, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

ACPC; Cocaine; Memantine; Place conditioning; Rats

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; COCAINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; MALE; NONHUMAN; PLACE PREFERENCE; RAT;

AMINO ACIDS, CYCLIC; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MEMANTINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0343962290     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Berger P., Farrel D., Sharp F., Skolnick P.: Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex. Neurosci. Lett., 1994, 168, 147-150.
2. Biała G., Kotlińska J.: Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Alcohol Alcoholism, 1999, 34, 175-182.
3. Carr G. D., Fibiger H. C., Phillips A. G.: Conditioned place preference as a measure of drug reward. In: Neuropharmacological Basis of Reward. Eds. Liebman J. M., Cooper S. J., Oxford University Press, 1989, 264-319.
4. Cervo L., Samanin R.: Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res., 1995, 673, 242-250.
5. Chen J., Graham S., Moroni F., Simon R.: A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J. Pharmacol. Exp. Ther., 1990, 102, 551-553.
6. Chiamulera C., Costa S., Reggiani A.: Effect of NMDA-insensitive and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology, 1990, 102, 551-553.
7. Collins E. D., Ward A. S., McDowell D. M., Foltin R. W., Fischman M. W.: The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav. Pharmacol , 1998, 9, 587-598.
8. Danysz W., Essmann U., Bresink I., Wilke R.: Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav., 1994, 48, 111-118.
9. Danysz W., Parsons C. G.: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev., 1998, 50, 597-664.
10. Di Chiara G., Imperato A.: Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc. Nat. Acad. Sci. USA, 1988, 85, 54274-54278.
11. Faiman C. P., Viu E., Skolnick P., Trullas R.: Differential effects of compounds that act at strychnine-insensitive glycine receptors in a punishment procedure. J. Pharmacol. Exp. Ther., 1994, 270, 528-533.
12. Fossom L. H., Von Lubitz D. K., Lin R. C., Skolnick P.: Neuroprotective actions of 1 -aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites. Neurol. Res., 1995, 17, 265-269.
13. Haggerty G. C., Charles V., Lanthorn T. H.: Acute vacuolization study of subcutaneously administered D-cycloserine (DCS) in Sprague Dawley rats. Soc. Neurosci. Abstr., 1993, 19, 1888.
14. Hargreaves R. J., Rigby M., Smith D., Hill R. G.: Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Brit. J. Pharmacol., 1993, 110, 36-42.
15. Hyytiä P., Bäckström P., Liljequist S.: Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur. J. Pharmacol., 1999, 378, 9-16.
16. Imperato A., Honore T., Jensen L. H.: Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res., 1990, 530, 223-228.
17. Karcz-Kubicha M., Jessa M., Nazar M., Plaźnik A., Hartmann S., Parsons C. G., Danysz W.: Anxiolytic activity of glycine-B antagonists and partial agonists - no relation to intrinsic activity in the patch clamp. Neuropharmacology, 1997, 36, 1355-1367.
18. Karler R., Calder I. D., Turkanis S. A.: DNQX blockade of amphetamine behavioral sensitization. Brain Res., 1991, 552, 295-300.
19. Koek W., Colpaert F. C.: Selective blockade of N-methyl-D-aspartate induced convulsions by antagonists and putative glycine antagonists relationship with phencyclidine-like behavioural effects. J. Pharmacol. Exp. Ther., 1990, 252, 349-357.
20. Kolesnikov Y. A., Maccechini M. L., Pasternak G. W.: 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci., 1994, 55, 1393-1398.
21. Kotlińska J., Biała G.: Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine-and cocaine-induced place preference. Pol. J. Pharmacol., 1999, 51, 323-330.
22. Krebs M., Desce-J., Kemel M., Gauchy C., Godeheu G., Cheramy A., Glowinski J.: Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem., 1991, 56, 81-85.
23. Matsumoto R. R., Brackett R. L., Kanthasamy A. G.: Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity. Eur. J. Pharmacol., 1997, 338, 233-242.
24. Murata S., Kawasaki K.: Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor/channel complex. Eur. J. Pharmacol., 1993, 239, 9-15.
25. Nahum-Levy R., Fossom L. H., Skolnick P., Benveniste M.: Putative partial agonist 1-aminocyclopropane-carboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors. Mol. Pharmacol., 1999, 56, 1207-1218.
26. Papp M., Moryl E., Maccecchini M. L.: Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur. J. Pharmacol., 1996, 317, 191-196.
27. Parsons C. G., Danysz W., Quack G.: Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect., 1998, 11, 523-569.
28. Parsons C. G., Danysz W., Quack G.: Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology, 1999, 38, 735-767.
29. Piasecki J., Koros E., Dyr W., Kostowski W., Danysz W., Bieńkowski P.: Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine. Eur. J. Pharmacol., 1998, 354, 135-143.
30. Popik P., Danysz W.: Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J. Pharmacol. Exp. Ther., 1997, 280, 854-865.
31. Popik P., Kolasiewicz W.: Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn-Schmied. Arch. Pharma-col., 1999, 359, 288-294.
32. Popik P., Rygielska Z.: A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats. J. Physiol. Pharmacol., 1999, 50, 139-151.
33. Popik P., Skolnick P.: The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol. Biochem. Behav., 1996, 53, 791-797.
34. Ranaldi R., French E., Roberts D. C.: Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. Psychopharmacology, 1996, 128, 83-88.
35. Schenk S., Valadez A., Worley C. M., McNamara C.: Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (dizocilpine). Behav. Pharmacol., 1993, 4, 652-659.
36. Skolnick P., Marvizon J. C. G., Jackson B. W., Monn J. A., Pice K. C., Lewin A. P.: Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci., 1989, 45, 1647-1656.
37. Trujillo K. A., Akil H.: Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Dependence, 1995, 38, 139-154.
38. Trullas R., Folio T., Young A., Miller R., Boje K., Skolnick P.: 1 -Aminocyclopropanecarboxylates exhibit aritidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 1991, 203, 379-385.
39. Trullas R., Jackson B., Skolnick P.: Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav., 1989, 34, 313-316.